Updates from the 2023 American Society of Hematology Annual Meeting
Updates from the 2023 American Society of Hematology Annual Meeting The Lymphoma Research Foundation (LRF)…
Updates from the 2023 American Society of Hematology Annual Meeting The Lymphoma Research Foundation (LRF)…
Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants New York, NY…
Updates from the 2022 American Society of Hematology Annual Meeting The Lymphoma Research Foundation (LRF)…
ASH 2022: Primary Central Nervous System Lymphoma Survival Improved with Consolidation Therapy Consolidation with either…
ASH 2022: Addition of Lenalidomide to Rituximab Therapy is Associated with Improved Survival in Relapsed/Refractory…
ASH 2022: Updated Index Improves Prognostication for Survival in Advanced-Stage Hodgkin Lymphoma Models that have…
ASH 2022: Durable Responses Observed with Mosunetuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma In research presented…